Creekmur Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Creekmur Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$9.92K	Sell	491 -23	-4%	-$404	﹤0.01%	518
2025 Q2	$8.62K	Buy	514 +94	+22%	+$1.52K	﹤0.01%	539
2025 Q1	$6.46K	Sell	420 -35	-8%	-$625	﹤0.01%	531
2024 Q4	$10K	Hold	455	–	–	﹤0.01%	426
2024 Q3	$8.2K	Buy	+455	New	+$7.96K	﹤0.01%	468

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Creekmur Asset Management's TEVA Position: Q3 2025 in Review

Creekmur Asset Management reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 4.5% in Q3 2025, selling an estimated $404 and leaving 491 shares worth $9.92K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Creekmur Asset Management first reported a position in TEVA in Q3 2024 and has held it in 5 quarters since. The position peaked at $10K in Q4 2024. 553 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

Creekmur Asset Management held 491 shares of Teva Pharmaceutical Industries Limited worth $9.92K as of Q3 2025.
Creekmur Asset Management sold 23 Teva Pharmaceutical Industries Limited shares in Q3 2025, an estimated $404.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #518 holding.
Creekmur Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 5 quarters since.
Creekmur Asset Management's Teva Pharmaceutical Industries Limited position peaked at $10K in Q4 2024.
553 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.